养老院多重用药居民减药的发生率及相关因素
本研究基于欧洲SHELTER研究数据,纳入1843名多重用药(≥5种药物)的养老院居民,随访12个月,评估减药(用药数量减少)的1年发生率及相关因素。结果显示减药发生率为35.7%,认知障碍、机构内有老年科医生及基线用药数量多与减药概率升高相关,而女性、心力衰竭和癌症与减药概率降低相关。
要点
- 养老院多重用药居民1年内减药发生率为35.7%。
- 认知障碍、机构配备老年科医生及基线用药多与减药概率升高相关。
- 女性、心力衰竭和癌症与减药概率降低相关。
核心结论
- 减药在养老院多重用药居民中较常见,并与个体因素和组织因素相关。
- 未来需要更多关于减药的证据,并明确如何撤药的策略。
研究设计与样本
- 纵向多中心队列研究,基于SHELTER研究数据,纳入欧洲及以色列养老院中1843名多重用药居民,随访12个月。
主要发现
- 基线平均用药数量为8.6种(标准差2.9)。
- 随访期间658名居民(35.7%)发生减药。
- 认知障碍(轻/中度 vs 完整:OR 1.41,95%CI 1.11-1.79;重度 vs 完整:OR 1.60,95%CI 1.23-2.09)、机构内有老年科医生(OR 1.41,95%CI 1.15-1.72)及基线用药数量(OR 1.10,95%CI 1.06-1.14)与减药概率升高相关。
- 女性(OR 0.76,95%CI 0.61-0.96)、心力衰竭(OR 0.69,95%CI 0.53-0.89)和癌症(OR 0.64,95%CI 0.45-0.90)与减药概率降低相关。
关键数值与推荐
- 多重用药定义为同时使用5种及以上药物。
- 减药定义为研究期间用药数量减少。
临床怎么用
- 在养老院多重用药居民中可考虑评估减药机会,尤其对认知障碍、用药数量多者及机构配备老年科医生时。
- 对女性、心力衰竭或癌症居民减药概率较低,临床应关注其用药优化需求。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess 1-year incidence and factors related to deprescribing in nursing home (NH) residents in Europe. DESIGN: Longitudinal multicenter cohort study based on data from the Services and Health for Elderly in Long TERm care (SHELTER) study. SETTING: NHs in Europe and Israel. PARTICIPANTS: 1843 NH residents on polypharmacy. METHODS: Polypharmacy was defined as the concurrent use of 5 or more medications. Deprescribing was defined as a reduction in the number of medications used over the study period. Residents were followed for 12 months. RESULTS: Residents in the study sample were using a mean number of 8.6 (standard deviation 2.9) medications at the baseline assessment. Deprescribing was observed in 658 residents (35.7%). Cognitive impairment (mild/moderate impairment vs intact, odds ratio [OR] 1.41, 95% confidence interval [CI] 1.11-1.79; severe impairment vs intact, OR 1.60, 95% CI 1.23-2.09), presence of the geriatrician within the facility staff (OR 1.41, 95% CI 1.15-1.72), and number of medications used at baseline (OR 1.10, 95% CI 1.06-1.14) were associated with higher probabilities of deprescribing. In contrast, female gender (OR 0.76, 95% CI 0.61-0.96), heart failure (OR 0.69, 95% CI 0.53-0.89), and cancer (OR 0.64, 95% CI 0.45-0.90) were associated with a lower probability of deprescribing. CONCLUSIONS AND IMPLICATIONS: Deprescribing is common in NH residents on polypharmacy, and it is associated with individual and organizational factors. More evidence is needed on deprescribing, and clear strategies on how to withdraw medications should be defined in the future.
引用
- Onder G, Vetrano DL, Villani ER, et al. Deprescribing in Nursing Home Residents on Polypharmacy: Incidence and Associated Factors. J Am Med Dir Assoc. 2019. PMID: 30853425. doi:10.1016/j.jamda.2019.01.130
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。